BerandaZEAL • CPH
add
Zealand Pharma A/S
Tutup sebelumnya
kr 663,00
Rentang hari
kr 610,00 - kr 685,00
Rentang tahun
kr 560,00 - kr 972,00
Kapitalisasi pasar
51,95Â M DKK
Volume Rata-Rata
181,53Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
CPH
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (DKK) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 9,06Â jt | -61,02% |
Biaya operasional | 404,79Â jt | 59,40% |
Laba bersih | -291,03Â jt | -9,93% |
Margin laba bersih | -3,21Â rb | -182,04% |
Penghasilan per saham | -4,12 | 10,43% |
EBITDA | -393,50Â jt | -63,38% |
Tarif pajak efektif | 0,20% | — |
Neraca
Total aset
Total liabilitas
| (DKK) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 8,23Â M | 403,72% |
Total aset | 9,51Â M | 380,08% |
Total liabilitas | 888,86Â jt | 129,59% |
Total ekuitas | 8,62 M | — |
Saham yang beredar | 70,65 jt | — |
Harga terhadap nilai buku | 5,44 | — |
Tingkat pengembalian aset | -10,35% | — |
Tingkat pengembalian modal | -10,83% | — |
Arus Kas
Perubahan kas bersih
| (DKK) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -291,03Â jt | -9,93% |
Kas dari operasi | -180,48Â jt | -403,25% |
Kas dari investasi | 150,75Â jt | 2.150,61% |
Kas dari pembiayaan | -4,60Â jt | -182,26% |
Perubahan kas bersih | -30,72Â jt | -147,35% |
Arus kas bebas | -117,23Â jt | -199,32% |
Tentang
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
Didirikan
1 Apr 1997
Situs
Karyawan
335
